Iowa Cochlear Implant Clinical Research Center Study of SSD Using Med-El Cochlear Implants

Sponsor
University of Iowa (Other)
Overall Status
Completed
CT.gov ID
NCT03929809
Collaborator
(none)
10
1
26
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to understand the speech perception in noise and in quiet and localization benefits in a laboratory setting in listeners that receive a cochlear implant in an ear with severe to profound hearing loss and have normal, or near-normal hearing in the opposite ear. We will also evaluate the functional benefit of restoring hearing to the impaired ear via questionnaires that subjects will be answering while listening in their natural environment.

Condition or Disease Intervention/Treatment Phase
  • Device: Cochlear Implant

Study Design

Study Type:
Observational
Actual Enrollment :
10 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Iowa Cochlear Implant Clinical Research Center Study of SSD Using Med-El Cochlear Implants
Actual Study Start Date :
Jun 20, 2019
Actual Primary Completion Date :
Aug 18, 2021
Actual Study Completion Date :
Aug 18, 2021

Arms and Interventions

Arm Intervention/Treatment
Adult Single-sided deafness

Adult subjects with unilateral single-sided deafness at least 6 months (to ensure stability of hearing loss), but no greater than 10 years will be implanted with a MED-EL Synchrony Cochlear Implant.

Device: Cochlear Implant
adults with unilateral hearing loss who wish to regain bilateral hearing will be implanted with a cochlear implant on their deafened ear.
Other Names:
  • MED-EL Synchrony
  • Outcome Measures

    Primary Outcome Measures

    1. Change in AzBio Sentences in Noise [Pre-operative baseline, 3, 6, 12 months post-activation]

      The percent correct of words from a list of 20 Target AzBio sentences will be played from 0° azimuth. A list of AzBio sentences will be played in multitalker babble which will be presented in three different conditions: 0° azimuth, S0N90, or S0N270°.

    2. Change in Localization [Pre-operative baseline, 3, 6, 12 months post-activation]

      Testing with 16 sounds played randomly from 1 of 8 loudspeakers in a 108 degree arc will be completed with non-implanted ear alone and everyday listening condition at 60 dBA. Subjects will be asked to identify which loudspeaker presented the sound. The RMS error in degrees will be calculated. A lower number indicates better localization ability.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Participants will be adults who utilize English as their primary language.

    2. Unilateral severe to profound sensorineural hearing loss for a duration of at least 6 months (to ensure stability of hearing loss), but no greater than 10 years.

    3. Contralateral ear with normal, or near-normal, hearing.

    4. Poorer ear (ear to be implanted): severe to profound sensorineural hearing loss, defined as pure-tone thresholds 70 dB HL or greater for the frequencies 500, 1000, 2000, 3000, and 4000 Hz with monosyllabic word understanding, as measured using the CNC Word Test at 60 dBA under earphones, less than or equal to 20%

    5. Better ear (contralateral ear): normal or near-normal hearing defined as pure-tone thresholds no poorer than 30 dB HL at 250, 500, 1000, 2000, and 3000 Hz and no poorer than 40 dB HL at 4000 Hz with monosyllabic word understanding, as measured using the CNC Word Test at 60 dBA under earphones, of greater than or equal to 85%.

    6. Willingness to comply with all study requirements.

    7. Patent cochlea and normal cochlear anatomy.

    Exclusion Criteria:
    1. Medical or psychological conditions that contraindicate undergoing surgery.

    2. Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.

    3. Unrealistic expectations on the part of the candidate and/or candidate's family, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices.

    4. Unwillingness or inability of the candidate to comply with all investigational requirements.

    5. Active middle ear infection.

    6. Tinnitus primary motivation for implantation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Iowa Iowa City Iowa United States 52241

    Sponsors and Collaborators

    • University of Iowa

    Investigators

    • Principal Investigator: Camille Dunn, PhD, University of Iowa

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Camille Dunn, Assistant Research Professor, University of Iowa
    ClinicalTrials.gov Identifier:
    NCT03929809
    Other Study ID Numbers:
    • 201901735
    First Posted:
    Apr 29, 2019
    Last Update Posted:
    Sep 29, 2021
    Last Verified:
    Sep 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 29, 2021